Thiazides in advanced chronic kidney disease-Reference-Cited by-同舟云学术

Thiazides in advanced chronic kidney disease

Published:2015-07 Issue:4 Volume:30 Page:366-372
ISSN:0268-4705
Container-title:Current Opinion in Cardiology
language:en
Short-container-title:

Author:

Sinha Arjun D.,Agarwal Rajiv

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. Improving Global Outcomes (KDIGO) CKD Work GroupKDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.;Kidney;Kidney Int Suppl,2013

2. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.;Go;N Engl J Med,2004

3. Chronic kidney disease as a coronary disease equivalent - a comparison with diabetes over a decade.;Debella;Clin J Am Soc Nephrol,2011

4. Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.;Muntner;Am J Kidney Dis,2010

5. Prevalence and prognostic role of resistant hypertension in chronic kidney disease patients.;De;J Am Coll Cardiol,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are thiazide diuretics ineffective with a glomerular filtration rate lower than 50 ml/min?;Die Innere Medizin;2023-12-19

2. How to optimize the use of diuretics in patients with heart failure?;Kardiologia Polska;2023-10-31

3. Practical use of single pill combinations in the treatment of hypertension — an analysis focused on perindopril-based combinations;Arterial Hypertension;2023-09-30

4. Effect of the combination of bumetanide plus chlorthalidone on hypertension and volume overload in patients with chronic kidney disease stage 4–5 KDIGO without renal replacement therapy: a double-blind randomized HEBE-CKD trial;BMC Nephrology;2022-09-20

5. Effect of Tolvaptan in Patients with Chronic Kidney Disease Stage G5, and Impact of Concomitant Use of Thiazide Diuretics: A Retrospective Cohort Study;Drugs - Real World Outcomes;2022-08-13